UPDATE: 10/28/2020 -- CAPACITY HAS BEEN REACHED and REGISTRATION IS NOW CLOSED. A video recording of the event will be shared afterwards. Thank you for your interest.
COVID-19 pandemic has impacted lives across the globe and West Virginia has been at the forefront of battling the pandemic. On Thursday, October 29, from 11 a.m. to 1 p.m. national, state health and research experts will lead a virtual discussion on policy and public health issues along with cutting edge research underway in the Mountain State.
The event will be divided into two segments. The first segment will begin at 11 a.m. and will feature a recorded keynote address by Anthony Fauci, MD, who serves as the director of the National Institute of Allergy and Infectious Diseases. He has been a national leader in the U.S. strategy in managing the COVID-19 pandemic. Due to his demanding schedule Dr. Fauci’s remarks will be pre-recorded. Following the keynote address, a panel of West Virginia health leaders will weigh in on current policy and public health issues relevant to the pandemic. Clay Marsh, MD, West Virginia COVID-19 Czar and Vice President and Executive Dean for Health Sciences at West Virginia University will participate along with Bill J. Crouch, Secretary for the West Virginia Department of Health and Human Resources.
At noon, the discussion will turn towards specific research projects that look at managing the pandemic and treating COVID-19 in new and novel ways. Presenters will include:
- F. Heath Damron, PhD, Assistant Professor and Director of the Vaccine Development Center, WVU Health Sciences
- Brian Hendricks, PhD, Research Assistant Professor, Department of Epidemiology, School of Public Health, WVU
- Ali Rezai, MD, FAANS, Executive Chair, Vice President of Neuroscience; Associate Dean, John D. Rockefeller IV tenured professor in neuroscience, School of Medicine, WVU
This event is the second installment of the West Virginia Clinical and Translational Science Institute’s “In Focus” series, highlighting specific topics in biomedical research. The first session discussed HIV and AIDS and the next session will highlight advances in addiction research.
Those wishing to attend the October 29 event must RSVP at the event webpage. Spots are limited. A link to the ZOOM webinar will be available upon registration.